Data / Form D filings / Avenue Biosciences Holding Inc
Avenue Biosciences Holding Inc: Form D filing
Avenue Biosciences Holding Inc, a biotechnology company in Menlo Park, CA, filed a Form D with the SEC in 2026. The latest, on January 28, 2026, reports $7.4 million sold of a $8.4 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 211 LAUREL STREET, Menlo Park, CA, 94025
- Phone
- (650) 285-8564
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2101752
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | New notice | $8,357,349 | $7,440,682 | $916,667 | 12 | Nov 20, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tero-Pekka Alastalo | Executive Officer, Director | |
| Katja Rosti | Executive Officer, Director | |
| Gabriel Poteliunaite | Director | |
| Jenny Engerfelt | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 26, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avenue Biosciences Holding Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.